Histamine: Clinical Trials

5 trials of Histamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown, 1 withdrawn. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Unknown 1, Withdrawn 1
Phase 22Unknown 1, Withdrawn 1

Follow Histamine: new trials by email Literature Review of Histamine trials Research Report on Histamine

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML)
Cohort 1, Ceplene® and Proleukin®, Cohort 2, Ceplene® and Proleukin®, Cohort 3, Ceplene® and Proleukin® - Leukemia, Myelomonocytic, Chronic
Phase 1 / Phase 2UnknownVastra Gotaland Region152017-02-152017-12-19
Immunologic Profile of Chronically Photodamaged Skin
Candida albicans antigen, histamine phosphate, imiquimod 5% cream - Photoaged Skin, Normal Skin
Phase 1CompletedUniversity of Michigan402016-06-062025-02-13
TransMEM Gas Exchange -- Project 1, Aim 2
ragweed, histamine, pseudoephedrine - Middle Ear Disease, Nasal Allergy
Phase 1CompletedCuneyt M. Alper842013-10-012020-02-07
Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes
Ceplene®, IL-2, Azacitidine, Azacitidine - Myelodysplastic Syndromes
Phase 1 / Phase 2WithdrawnGroupe Francophone des Myelodysplasies2011-03-012014-03-20
Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen
placebo, Histamine, AllerT1 - Allergic Rhinitis
Phase 1CompletedAnergis202008-02-012012-11-01

Conditions studied

Hypersensitivity (2)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Myelodysplastic Syndromes (1)  ·  Rhinitis, Allergic (1)

Sponsors

Anergis (1)  ·  Cuneyt M. Alper (1)  ·  Groupe Francophone des Myelodysplasies (1)  ·  University of Michigan (1)  ·  Vastra Gotaland Region (1)

Countries

United States (2)  ·  France (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Cuneyt M Alper, MD (1)  ·  Francois Spertini, MD (1)  ·  Pierre Fenaux, MD (1)  ·  Yolanda Helfrich, MD (1)

Results publications

PMID 23725004

NIH funding

P50DC007667 (1)